This inventor holds 1 USPTO granted patent. Top assignee: University of Memphis Research Foundation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Elton Jeffrey North: Innovator in Autotaxin Inhibition**
Introduction
Elton Jeffrey North, a distinguished inventor based in Memphis, TN, is recognized for his pioneering contributions to the field of biochemistry. With a unique focus on compounds that inhibit autotaxin enzymes, North's innovations have the potential to revolutionize approaches to cancer prevention.
Latest Patents
North holds a patent for "Diverse lead compound autotaxin inhibitors." This invention encompasses a variety of compounds, including naphthalenesulfones, phenylsulfones, and certain peptides featuring unnatural amino acids, all of which demonstrate effective inhibition of autotaxin. By reducing the size of reactive sites on the autotaxin enzyme, his compounds prevent the conversion of lysophosphatidyl choline to lysophosphatidic acid. This mechanism highlights a promising method for mitigating cancer generation linked to naturally occurring autotaxin within the human body. Additionally, the patent also includes methodologies for inactivating autotaxin to varying degrees using these compounds, broadening the scope of their therapeutic potential.
Career Highlights
Elton Jeffrey North is affiliated with the University of Memphis, where his research aims to bridge the gap between basic science and clinical application. His work on autotaxin inhibitors underscores his commitment to developing viable solutions aimed at improving human health.
Collaborations
In his innovative journey, North collaborates closely with colleagues, including Abby Louise Parrill-Baker and Daniel Lee Baker. Their joint efforts foster a collaborative environment that enhances research productivity and drives forward the exploration of novel therapeutic agents.
Conclusion
Elton Jeffrey North's contributions to the field of autotaxin inhibition demonstrate the significant impact of innovative research in cancer prevention. His patent not only showcases his inventive spirit but also holds promise for advancing therapeutic strategies and improving health outcomes for individuals at risk of cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile